Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-19

Clinical Trial Update: Remote EEG Device for Identification of Risk for Neonatal Seizures [NA]

View source ↗

Summary

A Mayo Clinic–led study evaluating a remote EEG device to identify risk of neonatal seizures was withdrawn from clinical trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Neonatal Encephalopathy | NA | Status: WITHDRAWN